Wednesday, February 1, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Chemistry AND Physics

Researcher receives patent for Huntington’s disease treatment

April 1, 2016
in Chemistry AND Physics
0
Share on FacebookShare on Twitter
IMAGE

The University of Wyoming recently was awarded a patent for a method that potentially could be used to help treat patients with Huntington's disease and other neurodegenerative diseases.

Jonathan Fox, a veterinary pathologist and associate professor in the UW Department of Veterinary Sciences, is the inventor. He studies mice genetically engineered to have Huntington's disease.

Huntington's disease, which affects about 30,000 people in the United States, is caused by a protein called huntingtin that, when in the mutant form, misfolds and accumulates in neurons. This eventually results in degeneration in brain areas important for movement, mental health and memory. Fox says that, currently, there are no treatments that are effective in slowing progression of the human disease.

Fox developed a method for decreasing the levels of the disease-causing mutant huntingtin protein. This is accomplished by increasing expression of specific proteins that can decrease levels of mutant huntingtin protein in cells.

"Increasing the expression levels of these protective proteins, or using chemical activators of their enzymatic activities, is a potential way to target the proximal cause of Huntington's disease, which is mutant huntingtin protein," Fox says. "Since other protein misfolding neurodegenerative diseases have many features in common with Huntington's disease, the present method may be applicable to other protein misfolding neurodegenerative diseases."

The findings have created a new marketing opportunity for therapeutic development, says Davona Douglass, director of the Research Products Center (RPC) at UW. The RPC is UW's technology transfer office that helps inventors patent and license intellectual property. It also helps entrepreneurs and inventors throughout the state to identify, protect and commercialize their intellectual property.

"More research must be done, but we look forward to learning how this technology can be developed for use in a therapeutic setting, potentially providing relief for those individuals carrying the disease mutation," Douglass says. "We hope this patented innovation can regulate the huntington protein misfolds that accumulate in the brain and ultimately result in loss of brain functions."

###

To learn more about licensing and marketing opportunities, visit the RPC website at http://www.uwyo.edu/rpc, call Douglass at (307) 766-2509, or email her at [email protected]

Media Contact

Jonathan Fox
[email protected]
307-766-9953

http://www.uwyo.edu

Share25Tweet16Share4ShareSendShare
  • blank

    Null results research now published by major behavioral medicine journal

    548 shares
    Share 219 Tweet 137
  • Seawater split to produce green hydrogen

    65 shares
    Share 26 Tweet 16
  • Mount Sinai launches phase 1 US trial of NDV-HXP-S, an Egg-based investigational COVID-19 vaccine, in healthy adults previously immunized against COVID-19

    67 shares
    Share 27 Tweet 17
  • Dogs’ average age at cancer diagnosis is associated with size, sex, breed

    65 shares
    Share 26 Tweet 16
  • Face masks cut distance airborne pathogens could travel in half, new study finds

    181 shares
    Share 72 Tweet 45
  • Increase in marine heatwaves expected to affect organisms at bottom of food chain, study suggests

    66 shares
    Share 26 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin

Null results research now published by major behavioral medicine journal

Hydrogen peroxide from tea and coffee residue: New pathway to sustainability

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 205 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In